Development
Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.40-40.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.70K | 6.40K | 12.40K | 13.60K | 14.80K |
| Total Other Revenue | -- | -- | -- | -- | -1.60K |
| Total Revenue | 8.70K | 6.40K | 12.40K | 13.60K | 13.20K |
| Cost of Revenue | 800.00 | -- | -- | -- | 0.00 |
| Gross Profit | 7.90K | 6.40K | 12.40K | 13.60K | 13.20K |
| SG&A Expenses | 166.30K | 74.50K | 57.60K | 50.20K | 47.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 167.10K | 74.50K | 57.60K | 50.20K | 47.90K |
| Operating Income | -158.40K | -68.10K | -45.20K | -36.60K | -34.60K |
| Income Before Tax | -158.40K | -68.10K | -45.20K | -36.60K | -33.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.16 | -0.07 | -0.05 | -0.04 | -0.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -158.40K | -68.10K | -45.20K | -36.60K | -33.10K |
| EBIT | -158.40K | -68.10K | -45.20K | -36.60K | -34.60K |
| EBITDA | -158.10K | -67.80K | -44.90K | -36.30K | -34.30K |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 119.98M | 119.98M | 119.98M | 119.98M | 119.98M |
| Average Diluted Shares Outstanding | 119.98M | 119.98M | 119.98M | 119.98M | 119.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |